AAAAAA
Results: 1-25/35
Authors:
BRUSERUD O
Citation: O. Bruserud, IL-4, IL-10 AND IL-13 IN ACUTE MYELOGENOUS LEUKEMIA, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 187-198
Authors:
FROSTAD S
BJERKNES R
ABRAHAMSEN JF
OLWEUS J
BRUSERUD O
Citation: S. Frostad et al., INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) HAS A COSTIMULATORY EFFECT ON PROLIFERATION OF COMMITTED PROGENITORS DERIVED FROM HUMAN UMBILICAL-CORDCD34(+) CELLS, Stem cells, 16(5), 1998, pp. 334-342
Authors:
BRUSERUD O
FOSS B
Citation: O. Bruserud et B. Foss, SERUM THROMBOPOIETIN LEVELS IN ACUTE-LEUKEMIA PATIENTS WITH CHEMOTHERAPY-INDUCED CYTOPENIA - INVERSE CORRELATION BETWEEN SERUM LEVELS AND PLATELET COUNTS, Leukemia, 12(10), 1998, pp. 1653-1653
Authors:
BRUSERUD O
FOSS B
Citation: O. Bruserud et B. Foss, SERUM THROMBOPOIETIN LEVELS IN ACUTE-LEUKEMIA PATIENTS WITH CHEMOTHERAPY-INDUCED CYTOPENIA - INVERSE CORRELATION BETWEEN SERUM LEVELS AND PLATELET COUNTS - RESPONSE TO SHINJO,K ET-AL, Leukemia, 12(10), 1998, pp. 1654-1654
Authors:
BRUSERUD O
Citation: O. Bruserud, CELLULAR IMMUNE-RESPONSES IN ACUTE-LEUKEMIA PATIENTS WITH SEVERE CHEMOTHERAPY-INDUCED LEUKOPENIA - CHARACTERIZATION OF THE CYTOKINE REPERTOIRE OF CLONOGENIC T-CELLS, Cancer immunology and immunotherapy, 46(4), 1998, pp. 221-228
Authors:
BRUSERUD O
ULVESTAD E
BERENTSEN S
BERGHEIM J
NESTHUS I
Citation: O. Bruserud et al., T-LYMPHOCYTE FUNCTIONS IN ACUTE-LEUKEMIA PATIENTS WITH SEVERE CHEMOTHERAPY-INDUCED CYTOPENIA - CHARACTERIZATION OF CLONOGENIC T-CELL PROLIFERATION, Scandinavian journal of immunology, 47(1), 1998, pp. 54-62
Authors:
FOSS B
BRUSERUD O
Citation: B. Foss et O. Bruserud, EFFECT OF PLATELET-DERIVED GROWTH-FACTOR ON ACUTE MYELOGENOUS LEUKEMIA BLASTS, Bone marrow transplantation, 21, 1998, pp. 360-360
Authors:
BASSOE CF
BRUSERUD O
PRYME IF
VEDELER A
Citation: Cf. Bassoe et al., RIBOSOMAL-PROTEINS SUSTAIN MORPHOLOGY, FUNCTION AND PHENOTYPE IN ACUTE MYELOID-LEUKEMIA BLASTS, Leukemia research, 22(4), 1998, pp. 329-339
Authors:
BRUSERUD O
FOSS B
HERVIG T
Citation: O. Bruserud et al., EFFECTS OF NORMAL PLATELETS ON PROLIFERATION AND CONSTITUTIVE CYTOKINE SECRETION BY HUMAN ACUTE MYELOGENOUS LEUKEMIA BLASTS, Platelets, 8(6), 1997, pp. 397-404
Authors:
BRUSERUD O
ULVESTAD E
HALSTENSEN A
BERENTSEN S
BERGHEIM J
NESTHUS I
Citation: O. Bruserud et al., INTERLEUKIN-4 RESPONSES IN ACUTE-LEUKEMIA PATIENTS WITH SEVERE CHEMOTHERAPY-INDUCED LEUKOPENIA, European journal of haematology, 59(5), 1997, pp. 269-276
Authors:
BRUSERUD O
Citation: O. Bruserud, SERUM LEVELS OF SOLUBLE ICAM-1 IN ACUTE-LEUKEMIA PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA, Leukemia, 11(9), 1997, pp. 1596-1597
Authors:
BRUSERUD O
Citation: O. Bruserud, INCREASES OF SICAM-1 IN NEUTROPENIC FEVER - COMMENT, Leukemia, 11(9), 1997, pp. 1597-1597
Authors:
BRUSERUD O
FROSTAD S
Citation: O. Bruserud et S. Frostad, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN ACUTE MYELOGENOUS LEUKEMIA - A REVIEW OF PRESENT AND POSSIBLE FUTURE APPROACHES FOR GM-CSF THERAPY, The Cancer journal, 10(6), 1997, pp. 310-314
Authors:
BRUSERUD O
PAWELEC G
Citation: O. Bruserud et G. Pawelec, INTERLEUKIN-13 SECRETION BY NORMAL AND POSTTRANSPLANT T-LYMPHOCYTES -IN-VITRO STUDIES OF CELLULAR IMMUNE-RESPONSES IN THE PRESENCE OF ACUTE-LEUKEMIA BLAST CELLS, Cancer immunology and immunotherapy, 45(1), 1997, pp. 45-52
Authors:
FROSTAD S
BRUSERUD O
Citation: S. Frostad et O. Bruserud, EFFECTS OF INSULIN-LIKE-GROWTH-FACTOR (IGF-1) ON PROLIFERATION AND CYTOKINE SECRETION BY ACUTE MYELOGENOUS LEUKEMIA BLASTS, Experimental hematology, 25(8), 1997, pp. 433-433
Authors:
BRUSERUD O
Citation: O. Bruserud, T-LYMPHOCYTE FUNCTIONS IN ACUTE-LEUKEMIA PATIENTS WITH CHEMOTHERAPY-INDUCED LEUKOPENIA, Experimental hematology, 25(8), 1997, pp. 478-478
Authors:
BRUSERUD O
HALSTENSEN A
PEEN E
SOLBERG CO
Citation: O. Bruserud et al., SERUM LEVELS OF ADHESION MOLECULES AND CYTOKINES IN PATIENTS WITH ACUTE-LEUKEMIA, Leukemia & lymphoma, 23(5-6), 1996, pp. 423-430
Authors:
BRUSERUD O
AASEN I
AKSELSEN PE
BERGHEIM J
RASMUSSEN G
NESTHUS I
Citation: O. Bruserud et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA) IN ACUTE-LEUKEMIA - IL1RA IS BOTH SECRETED SPONTANEOUSLY BY MYELOGENOUS LEUKEMIA BLASTS AND IS A PART OF THE ACUTE-PHASE REACTION IN PATIENTS WITH CHEMOTHERAPY-INDUCEDLEUKOPENIA, European journal of haematology, 57(1), 1996, pp. 87-95
Authors:
BRUSERUD O
Citation: O. Bruserud, EFFECTS OF INTERLEUKIN-13 ON CYTOKINE SECRETION BY HUMAN ACUTE MYELOGENOUS LEUKEMIA BLASTS, Leukemia, 10(9), 1996, pp. 1497-1503
Authors:
BRUSERUD O
Citation: O. Bruserud, IN-VITRO EFFECTS OF R-VERAPAMIL ON THE CYTOKINE ENVIRONMENT AND T-LYMPHOCYTE PROLIFERATION WHEN HUMAN T-LYMPHOCYTE ACTIVATION TAKES PLACE IN THE PRESENCE OF ACUTE MYELOGENOUS LEUKEMIA BLASTS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 71-78
Authors:
BRUSERUD O
MENTZONI L
FOSS B
BERGHEIM J
BERENTSEN S
NESTHUS I
Citation: O. Bruserud et al., HUMAN T-LYMPHOCYTE ACTIVATION IN THE PRESENCE OF ACUTE MYELOGENOUS LEUKEMIA BLASTS - STUDIES OF ALLOSTIMULATED INTERFERON-GAMMA SECRETION, Cancer immunology and immunotherapy, 43(5), 1996, pp. 275-282
Authors:
BRUSERUD O
PAWELEC G
Citation: O. Bruserud et G. Pawelec, HUMAN T-LYMPHOCYTE ACTIVATION IN THE PRESENCE OF ACUTE MYELOGENOUS LEUKEMIA BLASTS - STUDIES OF NORMAL POLYCLONAL T-CELLS AND T-LYMPHOCYTE CLONES DERIVED EARLY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Cancer immunology and immunotherapy, 42(3), 1996, pp. 133-140
Authors:
BRUSERUD O
Citation: O. Bruserud, EFFECTS OF ENDOGENOUS INTERLEUKIN-1 ON BLAST CELLS DERIVED FROM ACUTEMYELOGENOUS LEUKEMIA PATIENTS, Leukemia research, 20(1), 1996, pp. 65-73
Authors:
PAWELEC G
MAX H
HALDER T
BRUSERUD O
MERL A
DASILVA P
KALBACHER H
Citation: G. Pawelec et al., BCR ABL LEUKEMIA ONCOGENE FUSION PEPTIDES SELECTIVELY BIND TO CERTAINHLA-DR ALLELES AND CAN BE RECOGNIZED BY T-CELLS FOUND AT LOW-FREQUENCY IN THE REPERTOIRE OF NORMAL DONORS/, Blood, 88(6), 1996, pp. 2118-2124
Authors:
BRUSERUD O
MENTZONI L
BUHRING HJ
PAWELEC G
Citation: O. Bruserud et al., EFFECTS OF HEMATOPOIETIC GROWTH-FACTORS ON INTERLEUKIN-6 SECRETION BYBLAST CELLS DERIVED FROM ACUTE MYELOGENOUS LEUKEMIA PATIENTS, Acta haematologica, 96(3), 1996, pp. 155-161